...
search icon
tdacw-img

Translational Development Acquisition Equity Warrants 18 Dec 2029, Common Stock

TDACW

NMQ

$0.21

+$0

(0%)

1D

Analyst Forecast

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$0
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0

About Translational Development Acquisition Equity Warrants 18 Dec 2029, Common Stock

Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business, industry, sector or geographical location. The Company intends to focus on industries that complement its management team’s background, and to capitalize on the ability of its management team to identify and acquire a business. The Company has neither engaged in any operations nor generated any revenues. more

Returns

Data is not properly formatted.

Financials

Dec '16Dec '17Dec '18Dec '19Dec '205YR TREND
Total Revenue-----[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true}]
Cost of Revenue-387.00699.33K-1.39M[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":0.03,"profit":true},{"date":"2018-12-31","value":50.47,"profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true}]
Gross Profit-(387.00)--(1.39M)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":-38700,"profit":false},{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-138573800,"profit":false}]
Gross Margin-(Infinity%)--(Infinity%)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":null,"profit":false},{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false}]
Operating Expenses-387.00699.33K1.10M1.39M[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":0.03,"profit":true},{"date":"2018-12-31","value":50.47,"profit":true},{"date":"2019-12-31","value":79.39,"profit":true},{"date":"2020-12-31","value":100,"profit":true}]
Operating Income(1.97K)(387.00)(699.33K)(1.10M)(1.39M)[{"date":"2016-12-31","value":-197000,"profit":false},{"date":"2017-12-31","value":-38700,"profit":false},{"date":"2018-12-31","value":-69933400,"profit":false},{"date":"2019-12-31","value":-110013800,"profit":false},{"date":"2020-12-31","value":-138573800,"profit":false}]
Total Non-Operating Income/Expense--(4.05K)-(11.18K)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":null,"profit":false},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false}]
Pre-Tax Income(1.97K)(387.00)1.78M3.22M(1.03M)[{"date":"2016-12-31","value":-0.06,"profit":false},{"date":"2017-12-31","value":-0.01,"profit":false},{"date":"2018-12-31","value":55.17,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-31.83,"profit":false}]
Income Taxes--374.64K690.82K217.09K[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":54.23,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":31.42,"profit":true}]
Income After Taxes--1.40M2.53M(1.24M)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":55.43,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-49.08,"profit":false}]
Income From Continuous Operations-(387.00)1.40M2.53M(809.05K)[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":-0.02,"profit":false},{"date":"2018-12-31","value":55.43,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-31.94,"profit":false}]
Income From Discontinued Operations-----[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true}]
Net Income(1.97K)(387.00)1.40M2.53M(1.24M)[{"date":"2016-12-31","value":-0.08,"profit":false},{"date":"2017-12-31","value":-0.02,"profit":false},{"date":"2018-12-31","value":55.43,"profit":true},{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-49.08,"profit":false}]
EPS (Diluted)-----[{"date":"2016-12-31","value":"-","profit":true},{"date":"2017-12-31","value":"-","profit":true},{"date":"2018-12-31","value":"-","profit":true},{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TDACW
Current Ratio 1.81

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TDACW
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TDACW
Debt Ratio Lower is generally better. Negative is bad. 0.63
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.37

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TDACW
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
EV/R 0.00
EV/Ebitda NM

FAQs

What is Translational Development Acquisition Equity Warrants 18 Dec 2029 share price today?

Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) share price today is $0.21

Can Indians buy Translational Development Acquisition Equity Warrants 18 Dec 2029 shares?

Yes, Indians can buy shares of Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) on Vested. To buy Translational Development Acquisition Equity Warrants 18 Dec 2029 from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TDACW stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Translational Development Acquisition Equity Warrants 18 Dec 2029 be purchased?

Yes, you can purchase fractional shares of Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) via the Vested app. You can start investing in Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) with a minimum investment of $1.

How to invest in Translational Development Acquisition Equity Warrants 18 Dec 2029 shares from India?

You can invest in shares of Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) via Vested in three simple steps:

  • Click on Sign Up or Invest in TDACW stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Translational Development Acquisition Equity Warrants 18 Dec 2029 shares
What is Translational Development Acquisition Equity Warrants 18 Dec 2029 price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Translational Development Acquisition Equity Warrants 18 Dec 2029 (TDACW) is 0.00

What is Translational Development Acquisition Equity Warrants 18 Dec 2029’s stock symbol?

The stock symbol (or ticker) of Translational Development Acquisition Equity Warrants 18 Dec 2029 is TDACW

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top